Breast Cancer, Metastatic research hub
4 indexed studies · 2 currently recruiting
- recruitingPHASE2
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
This study is for people with HER2-positive breast cancer that has spread. It's testing a new drug called evorpacept alongside standard treatments like trastuzumab and chemotherapy. Researchers want to see if this combination is safe and helps people whose cancer has grown despite previous treatments.
United States · Canada · France - active not recruitingNA
The Role of Stereo-tActic BoDy RadIotherApy iN Oligo-Progressive MalignanT Disease
This study looks at using very focused radiation, called SBRT, for breast and genito-urinary cancers that have spread a little but are otherwise stable. We want to see if SBRT can help treat these specific areas of cancer growth.
Canada - active not recruiting
Personalised Disease Monitoring in Metastatic Breast Cancer
This study looks at how blood tests could help manage metastatic breast cancer. It aims to see if certain markers in your blood can reliably tell doctors when you might need a scan, potentially reducing unnecessary imaging for patients with stable disease.
Sweden · United Kingdom - not yet recruitingPHASE2
First-Line Sacituzumab Govitecan in Advanced Untreated Triple-Negative Breast Cancer Patients.
This study looks at a new drug called Sacituzumab Govitecan (SG) for people with advanced triple-negative breast cancer who haven't had treatment for it before. It aims to see if SG can slow down the cancer's growth and if it works differently for certain types of this cancer.
Canada